- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT00836329
Improving Neurologic Outcomes in People With Diabetes Who Are Undergoing Heart Surgery
Improving Neurologic Outcomes in Diabetics Undergoing Cardiac Surgery
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Szczegółowy opis
People with diabetes who undergo heart surgery have a greater risk of experiencing a stroke and developing cognitive functioning problems than people without diabetes who undergo heart surgery. There may be a connection between disturbances in glucose metabolism, endothelial dysfunction, and poor neurological outcomes after heart surgery. People with diabetes who receive more intensive blood glucose management during and after heart surgery may have better neurological outcomes than people who control their blood glucose levels in a standard way. The purpose of this study is to evaluate the effectiveness of using a traditional method of controlling blood glucose levels versus a tailored, more intensive method of glucose control on neurological outcomes in people with diabetes who are undergoing heart surgery. Researchers will also examine genetic factors that may be associated with insulin resistance and inflammation.
This study will enroll people undergoing heart surgery. On the day before surgery, participants will undergo a blood collection and neuropsychological testing. They will then be randomly assigned to either a traditional method of blood glucose control or an intensive, tailored method of blood glucose control. Participants following the traditional method of blood glucose control may receive insulin several times a day, based on the results of glucose monitoring. Participants following the intensive, tailored method of blood glucose control will undergo hourly measurements of their glucose levels and receive insulin adjustments as needed to maintain a glucose level of 100-140 mg/dL. During surgery, all participants will undergo an ultrasound of their neck to monitor blood vessel activity. Additional blood samples will be collected during surgery, 6 hours after surgery, 24 hours after surgery, and upon hospital discharge or 5 days after surgery.
One week after surgery or just before leaving the hospital, participants will undergo a magnetic resonance imaging (MRI) procedure and neuropsychological testing. Before leaving the hospital, participants will take part in a diabetes education session and nutrition counseling. Three to 6 weeks and 6 months after surgery, participants will undergo repeat neuropsychological testing. Once a month for 6 months, participants who received the intensive, tailored method of blood glucose control will attend study visits at which time study researchers will monitor their diabetes.
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Faza 3
Kontakty i lokalizacje
Lokalizacje studiów
-
-
North Carolina
-
Winston-Salem, North Carolina, Stany Zjednoczone, 27057
- Wake Forest Baptist Medical Center
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- History of diabetes, elevated fasting blood glucose, elevated hemoglobin A1c, or elevation of these variables during the current hospital admission
- Scheduled to undergo coronary artery bypass graft (CABG) surgery
- Scheduled to undergo aortic valve replacement (AVR), mitral valve replacement (MVR), or both
- Scheduled to undergo valve replacement with CABG
Exclusion Criteria:
- Undergoing emergent (i.e., urgent) procedures
- Alzheimer's disease or similar dementias
- Severe claustrophobia
- Kidney insufficiency, as defined by serum creatine levels greater than 2.0 mg/dL
- Cannot be expected to complete neuropsychological testing
- Recent extensive, life threatening acute myocardial infarction (AMI)
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
---|---|
Eksperymentalny: Intensive Glucose Management
Participants will receive intensive glucose management.
|
Participants in the intensive glucose management group will undergo strict management of their blood glucose levels with a target whole blood glucose level of 100-140 mg/dL preoperatively, intraoperatively, and postoperatively in the intensive care unit (ICU).
Once meals are started, targets for glycemia management will be (a) fasting: 80-140 mg/dL, (b) postprandial: 140-180 mg/dL.
Prior to hospital discharge, participants will receive an in-depth diabetes education session.
After hospital discharge, participants will attend monthly study visits for 6 months so that study researchers can monitor their glycemia management.
|
Aktywny komparator: Traditional Glucose Management
Participants will receive a traditional method of glucose management.
|
Participants will receive traditional management of blood glucose levels while in the hospital.
They may receive insulin several times a day, based on the results of glucose monitoring.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Ramy czasowe |
---|---|
Proportion of participants with identifiable brain lesions detected by magnetic resonance imaging (MRI)
Ramy czasowe: Measured 1 week after surgery
|
Measured 1 week after surgery
|
Proportion of participants with new neuropsychological deficits (20% decline on two or more neuropsychological tests)
Ramy czasowe: Measured 6 months after surgery
|
Measured 6 months after surgery
|
Miary wyników drugorzędnych
Miara wyniku |
Ramy czasowe |
---|---|
Number of lesions, as measured by MRI
Ramy czasowe: Measured 1 week after surgery
|
Measured 1 week after surgery
|
Size of lesions, as measured by MRI
Ramy czasowe: Measured 1 week after surgery
|
Measured 1 week after surgery
|
Genetic analysis (i.e., predictive utility of haplotype assignment on primary outcomes)
Ramy czasowe: Measured 6 months after surgery
|
Measured 6 months after surgery
|
Neuropsychological deficits (i.e., predictive utility of neuropsychological performance on presence, number, and volume of lesions)
Ramy czasowe: Measured 6 months after surgery
|
Measured 6 months after surgery
|
Współpracownicy i badacze
Śledczy
- Główny śledczy: Edward H. Kincaid, MD, Wake Forest University Health Sciences
- Dyrektor Studium: Jorge Calles-Escandon, MD, Wake Forest University Health Sciences
- Dyrektor Studium: Donald W. Bowden, PhD, Wake Forest University Health Sciences
- Dyrektor Studium: David A. Stump, PhD, Wake Forest University Health Sciences
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Oszacować)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- 615
- R01HL089115-01 (Grant/umowa NIH USA)
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Intensive Glucose Management
-
University of Southern CaliforniaPendulum TherapeuticsWycofaneCukrzyca typu 2 | Objawy żołądkowo-jelitoweStany Zjednoczone
-
Singapore General HospitalKK Women's and Children's Hospital; SingHealth PolyclinicsZakończony
-
University Hospital, Basel, SwitzerlandRekrutacyjnyZanik mięśni u krytycznie chorychSzwajcaria
-
George Washington UniversityTranscultural Psychosocial Organization NepalZakończony
-
Boston Medical CenterBoston University; National Institute of Diabetes and Digestive and Kidney Diseases... i inni współpracownicyZakończony
-
Milton S. Hershey Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)ZakończonyNadciśnienie | Cukrzyca | HiperlipidemiaStany Zjednoczone
-
VA Pacific Islands Health Care SystemUnited States Department of Defense; Charles River AnalyticsZakończonyGniew | Zaburzenia stresowe, pourazoweStany Zjednoczone
-
Joslin Diabetes CenterZakończonyOtyłość | Cukrzyca typu 2
-
Eun-ji KimZakończonyZmiany skórneRepublika Korei